Life Sciences Alternative Funding - aVenture Asset Manager Research
Location
Scarsdale, NY, US
Founded
2013
Life Sciences Alternative Funding specializes in providing capital to commercial-stage life sciences companies. The firm focuses on debt financing and post-IPO debt rounds, typically investing around $15 million per deal. Their investment strategy targets companies that have already reached the commercial stage in the life sciences sector.
Notable portfolio companies include Harrow and VisionCare Ophthalmic Technologies. Life Sciences Alternative Funding's approach offers an alternative funding source for life sciences companies seeking capital beyond traditional equity investments, particularly those in later stages of development or post-IPO.
Life Sciences Alternative Funding - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages